These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Cardiac Investigations in Sudden Unexpected Death in DEPDC5-Related Epilepsy. Bacq A; Roussel D; Bonduelle T; Zagaglia S; Maletic M; Ribierre T; Adle-Biassette H; Marchal C; Jennesson M; An I; ; Picard F; Navarro V; Sisodiya SM; Baulac S Ann Neurol; 2022 Jan; 91(1):101-116. PubMed ID: 34693554 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of novel NPRL3 mutations identified in three families with focal epilepsy. Du S; Zeng S; Song L; Ma H; Chen R; Luo J; Wang X; Ma T; Xu X; Sun H; Yi P; Guo J; Huang Y; Liu M; Wang T; Liao WP; Zhang L; Liu JY; Tang B Sci China Life Sci; 2023 Sep; 66(9):2152-2166. PubMed ID: 37071290 [TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic features of GATOR1 complex-associated epilepsy. Yin K; Lei X; Yan Z; Yang Y; Deng Q; Lu Q; Zhang X; Wang M; Liu Q J Med Genet; 2023 Aug; 60(8):784-790. PubMed ID: 36604176 [TBL] [Abstract][Full Text] [Related]
12. Prevention of premature death and seizures in a Depdc5 mouse epilepsy model through inhibition of mTORC1. Klofas LK; Short BP; Zhou C; Carson RP Hum Mol Genet; 2020 May; 29(8):1365-1377. PubMed ID: 32280987 [TBL] [Abstract][Full Text] [Related]
13. Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3. Sim JC; Scerri T; Fanjul-Fernández M; Riseley JR; Gillies G; Pope K; van Roozendaal H; Heng JI; Mandelstam SA; McGillivray G; MacGregor D; Kannan L; Maixner W; Harvey AS; Amor DJ; Delatycki MB; Crino PB; Bahlo M; Lockhart PJ; Leventer RJ Ann Neurol; 2016 Jan; 79(1):132-7. PubMed ID: 26285051 [TBL] [Abstract][Full Text] [Related]
14. Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice. Yuskaitis CJ; Rossitto LA; Gurnani S; Bainbridge E; Poduri A; Sahin M Hum Mol Genet; 2019 Sep; 28(17):2952-2964. PubMed ID: 31174205 [TBL] [Abstract][Full Text] [Related]
15. Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy. Dawson RE; Nieto Guil AF; Robertson LJ; Piltz SG; Hughes JN; Thomas PQ Neurobiol Dis; 2020 Feb; 134():104640. PubMed ID: 31639411 [TBL] [Abstract][Full Text] [Related]
17. [DEPDC5, a new key to understand various epilepsies]. Ishida S Nihon Yakurigaku Zasshi; 2018; 152(6):281-285. PubMed ID: 30531098 [TBL] [Abstract][Full Text] [Related]
18. Seizure features and outcomes in 50 children with GATOR1 variants: A retrospective study, more favorable for epilepsy surgery. Wang H; Liu W; Zhang Y; Liu Q; Cai L; Jiang Y Epilepsia Open; 2023 Sep; 8(3):969-979. PubMed ID: 37259768 [TBL] [Abstract][Full Text] [Related]
19. Novel GATOR1 variants in focal epilepsy. Kovačević M; Janković M; Branković M; Milićević O; Novaković I; Sokić D; Ristić A; Shamsani J; Vojvodić N Epilepsy Behav; 2023 Apr; 141():109139. PubMed ID: 36848747 [TBL] [Abstract][Full Text] [Related]
20. NPRL2 down-regulation facilitates the growth of hepatocellular carcinoma via the mTOR pathway and autophagy suppression. Wang YC; Tsai MC; Chen YS; Hsieh PM; Hung CM; Lin HY; Hsu YC; Yeh JH; Hsiao P; Su YC; Ma CH; Lee CY; Lin CC; Shu CW; Li YC; Tsai MH; Lin JY; Peng WH; Yu ML; Lin CW Hepatol Commun; 2022 Dec; 6(12):3563-3577. PubMed ID: 36321403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]